Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study-Reference-Cited by-同舟云学术

Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study

Published:2014-05 Issue:5 Volume:20 Page:696-704
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Choi Inpyo,Yoon Suk Ran,Park Soo-Yeon,Kim Hanna,Jung Sol-Ji,Jang Ye Jin,Kang Minho,Yeom Young Il,Lee Jae-Lyun,Kim Dae-Young,Lee Young-Shin,Kang Young-Ah,Jeon Mijin,Seol Miee,Lee Jung-Hee,Lee Je-Hwan,Kim Hwa Jung,Yun Sung-Cheol,Lee Kyoo-Hyung

Funder

Ministry of Health and Welfare

Ministry of Education, Science and Technology

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference42 articles.

1. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning;Ogawa;Biol Blood Marrow Transplant,2006

2. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution;Rizzieri;J Clin Oncol,2007

3. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

4. Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome;Lee;Blood,2011

5. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts;Brunstein;Blood,2011

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy;American Journal of Hematology;2024-09-09

2. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy;Pharmaceutics;2024-08-29

3. A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy;Cancer Immunology, Immunotherapy;2024-07-03

4. Future directions in haploidentical hematopoietic stem cell transplantation;Hematology;2024-06-18

5. The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation;Frontiers in Immunology;2024-05-16